4 Recruiting Studies Using Trilaciclib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Trilaciclib
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
📍 Levine Cancer Institute — Charlotte, North Carolina
Metastatic Triple-Negative Breast Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Trilaciclib and Lurbinectidin
📍 Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
📍 Pharmacosmos Investigational Site — Oakland, California
Limited Stage Small Cell Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Breast Neoplasms
View Study & Checklist ➔